Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Mirum Pharmaceuticals

2 Disclosed Funding Rounds $130,000,000

0 Participating Investments


Pharmaceutical, Therapeutics, Health Care, Biotechnology

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

San Diego, California, United States, North America (US)

Organizations in San Diego in Pharmaceutical,
Organizations in San Diego in Therapeutics,
Organizations in San Diego in Health Care,
Organizations in San Diego in Biotechnology,
Organizations in California in Pharmaceutical,
Organizations in California in Therapeutics,
Organizations in California in Health Care,
Organizations in California in Biotechnology,
Organizations in United States in Pharmaceutical,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in North America in Pharmaceutical,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology

Investors in San Diego in Pharmaceutical,
Investors in San Diego in Therapeutics,
Investors in San Diego in Health Care,
Investors in San Diego in Biotechnology,
Investors in California in Pharmaceutical,
Investors in California in Therapeutics,
Investors in California in Health Care,
Investors in California in Biotechnology,
Investors in United States in Pharmaceutical,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in North America in Pharmaceutical,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Biotechnology

Greater San Diego Area (0 Investors) (0 Startups), West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups)

Founded date 01, 2018

Founders Susan Dubé, Alex Dorenbaum, Niall O'Donnell

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Date Round Raised Lead
December, 09, 2020 Post-IPO Equity $10,000,000 Oberland Capital
November, 07, 2018 Series A $120,000,000 New Enterprise Associates

Mirum Pharmaceuticals Investors (8)

Investor Lead? Round Participating Raise Date Partners
Oberland Capital Yes Post-IPO Equity $10,000,000 December, 09, 2020 -------
New Enterprise Associates Yes Series A $120,000,000 November, 07, 2018 -------
RiverVest No Series A $120,000,000 November, 07, 2018 -------
Deerfield Capital Management No Series A $120,000,000 November, 07, 2018 -------
Rock Springs Capital No Series A $120,000,000 November, 07, 2018 -------
Pappas Capital No Series A $120,000,000 November, 07, 2018 -------
Novo Holdings No Series A $120,000,000 November, 07, 2018 -------
Frazier Healthcare Partners No Series A $120,000,000 November, 07, 2018 -------